September 20, 2026

Pevita Pearce

Amylyx Pharmaceuticals Signals Strategic Turnaround with Positive Late-Stage Data for Avexitide amylyx-pharmaceuticals-signals-strategic-turnaround-with-positive-late-stage-data-for-avexitide

Amylyx Pharmaceuticals Signals Strategic Turnaround with Positive Late-Stage Data for Avexitide

Pevita Pearce August 18, 2026
In a significant pivot for the Boston-based biotechnology firm, Amylyx Pharmaceuticals announced Tuesday that its experimental drug,...
Read More Read more about Amylyx Pharmaceuticals Signals Strategic Turnaround with Positive Late-Stage Data for Avexitide
The Hidden Cost of Healing: Why Price Transparency in Breast Reconstruction Remains Elusive the-hidden-cost-of-healing-why-price-transparency-in-breast-reconstruction-remains-elusive

The Hidden Cost of Healing: Why Price Transparency in Breast Reconstruction Remains Elusive

Pevita Pearce August 17, 2026
For patients navigating the life-altering journey of breast reconstruction, the physical and emotional toll is immense. Yet,...
Read More Read more about The Hidden Cost of Healing: Why Price Transparency in Breast Reconstruction Remains Elusive
Closing the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care closing-the-coverage-gap-the-advancing-womens-health-coverage-act-seeks-to-modernize-post-mastectomy-care

Closing the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

Pevita Pearce August 16, 2026
ARLINGTON HEIGHTS, IL — In a landmark move aimed at harmonizing federal law with the rapid evolution...
Read More Read more about Closing the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care
FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Treatment Resistance fda-approves-gedatolisib-revtorpyk-for-advanced-hr-her2-breast-cancer-a-new-paradigm-in-overcoming-treatment-resistance

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Treatment Resistance

Pevita Pearce August 14, 2026
The landscape of metastatic breast cancer (MBC) treatment has undergone a significant transformation with the U.S. Food...
Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Treatment Resistance
Navigating the Information Crisis: Public Perception, Regulatory Challenges, and the Rise of AI-Driven Health Misinformation navigating-the-information-crisis-public-perception-regulatory-challenges-and-the-rise-of-ai-driven-health-misinformation

Navigating the Information Crisis: Public Perception, Regulatory Challenges, and the Rise of AI-Driven Health Misinformation

Pevita Pearce August 13, 2026
August 13, 2026 | Volume 52 In an era defined by rapid technological advancement and deep-seated political...
Read More Read more about Navigating the Information Crisis: Public Perception, Regulatory Challenges, and the Rise of AI-Driven Health Misinformation

You may have missed

the-great-insurance-debate-dissecting-the-role-of-health-insurers-in-americas-fiscal-crisis

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Muslim September 20, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution-2

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Lina Hope September 20, 2026
salk-scientists-unveil-estrogen-related-receptors-as-key-to-unlocking-energy-metabolism-and-combating-muscle-fatigue

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

Ammar Sabilarrohman September 20, 2026
the-architecture-of-hope-mapping-the-centuries-long-evolution-of-breast-cancer-treatment

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment

Suro Senen September 20, 2026